Cargando…
Targeted next-generation sequencing expands the spectrum of mitochondrial disorders
Next-generation sequencing has become a powerful tool for testing genetically and clinically heterogeneous conditions such as mitochondrial disorders. A recent study published in Science Translational Medicine underscores the considerable clinical benefits of targeted next-generation sequencing for...
Autor principal: | Hahn, Si Houn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446272/ https://www.ncbi.nlm.nih.gov/pubmed/22445237 http://dx.doi.org/10.1186/gm321 |
Ejemplares similares
-
Next generation sequence analysis for mitochondrial disorders
por: Vasta, Valeria, et al.
Publicado: (2009) -
Targeted next-generation sequencing for routine clinical screening of mutations
por: Weaver, Jamie MJ, et al.
Publicado: (2011) -
A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022) -
Next-generation sequencing to monitor the spread of antimicrobial resistance
por: Otto, Michael
Publicado: (2017) -
Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity
por: DaRe, Jeana T, et al.
Publicado: (2013)